Carnitine Supplementation and VLCAD Deficiency There has been considerable controversy regarding the role of Lcarnitine (Carnitor®, Sigma-Tau Pharmaceuticals, Inc.) and its value as a supplemental therapy in fat oxidati

First Page		Document Content
Date: 2012-05-31 13:41:07 Dietary supplements Quaternary ammonium compounds Medium-chain acyl-coenzyme A dehydrogenase deficiency Carnitine Very long-chain acyl-coenzyme A dehydrogenase deficiency Rare diseases Fatty-acid metabolism disorder Inborn error of lipid metabolism Health Chemistry Medicine		Carnitine Supplementation and VLCAD Deficiency There has been considerable controversy regarding the role of Lcarnitine (Carnitor®, Sigma-Tau Pharmaceuticals, Inc.) and its value as a supplemental therapy in fat oxidati Add to Reading List Source URL: www.fodsupport.org Download Document from Source Website File Size: 38,35 KB Share Document on Facebook

	DOCX Document DocID: 1wwhs - View Document
	DOCX Document DocID: 1wv76 - View Document
	PDF Document DocID: 1w4hN - View Document
	-Application for Renewal of RDMM Catalyst Grants This application is to be used by the Network’s Scientific Advisory Committee (SAC) to determine as to whether to provide an additional year of funding ($ DocID: 1vceh - View Document
	MULTISYSTEMIC RARE DISEASES DocID: 1v3AN - View Document